Top in women’s health: Decrease in contraceptive use; increase in perinatal PTSD diagnoses
The use of most contraceptive methods steadily decreased from 2019 to 2022, with the exception of vasectomy, according to results published in JAMA Network Open.
Researchers observed that new prescriptions for contraceptives decreased from 25 million in 2019 to fewer than 22 million in 2022. The results also demonstrated a workforce shift in contraception distribution, with more advanced practice clinicians providing IUDs, implants and new prescriptions.
“In 2022, Dobbs v. Jackson Women’s Health Organization dramatically changed the landscape of reproductive health, causing ripple effects that will extend beyond abortion care,” Julia Strasser, DrPH, MPH, an assistant professor in the department of health policy and management at the Milken Institute School of Public Health at George Washington University, and colleagues wrote. “Contraception may be especially vulnerable to further restrictions and barriers, both to those seeking care and those providing it.”
It was the top story in women’s health last week.
In another top story, from 2008 to 2020, the overall predicted probability of perinatal PTSD diagnosis increased for all ethnicities and races and was highest for white women at all time points, according to a cross-sectional study published in Health Affairs.
Read these and more top stories in women’s health below:
Use of most contraceptive methods steadily decreased from 2019 to 2022
Use of most contraceptive methods steadily decreased from 2019 to 2022, except for vasectomy, with more advanced practice clinicians and fewer physicians providing new contraceptive prescriptions, researchers reported. Read more.
Perinatal PTSD significantly increased from 2008 to 2020, varying based on race, ethnicity
Perinatal PTSD diagnoses significantly increased from 2008 to 2020, with rates varying based on race and ethnicity, according to a cross-sectional study published in Health Affairs. Read more.
Survey: Menopause symptoms disrupt work life for more than three-quarters of women
Menopause symptoms substantially impact work life for more than three-quarters of women, highlighting the need for more awareness and implementation of menopause support measures in the workplace, researchers reported in Menopause. Read more.
Prescription digital therapeutic for postpartum depression receives FDA 510(k) clearance
An 8-week prescription digital therapeutic for treatment of postpartum depression symptoms received FDA 510(k) clearance, according to a press release from Curio Digital Therapeutics. Read more.
Increased mortality risk for BRCA carriers diagnosed within 10 years postpartum
Women with breast cancer and germline BRCA pathogenic variants had increased all-cause mortality risk if diagnosis occurred within 10 years postpartum, according to cohort study results published in JAMA Network Open. Read more.